ADVFN - ニュース

S&P 500

5,277.51

0.80%

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/01	21 : 30	PR Newswire (Canada)	Message from the Governor General on National Indigenous History Month
2024/06/01	21 : 30	PR Newswire (US)	Xtalks Announces its Life Science Webinar Calendar for June 2024
2024/06/01	21 : 30	PR Newswire (Canada)	Message de la gouverneure générale à l'occasion du Mois national de l'histoire autochtone
2024/06/01	21 : 21	Cointelegraph	3 signs that Ethereum price will finally break $4K in June	COIN:ETHUSD	Ethereum
2024/06/01	21 : 15	GlobeNewswire Inc.	Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/01	21 : 10	Business Wire	Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting	NYSE:NUVB	Panacea Acquisition Corp
2024/06/01	21 : 05	GlobeNewswire Inc.	Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting	NASDAQ:YMAB	Y mAbs Therapeutics Inc
2024/06/01	21 : 05	PR Newswire (US)	Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024	NASDAQ:JAZZ	Jazz Pharmaceuticals PLC
2024/06/01	21 : 01	Alliance News	EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	LSE:TGR	Tirupati Graphite Plc
2024/06/01	21 : 01	Alliance News	EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	LSE:TPX	Tpximpact Holdings Plc
2024/06/01	21 : 01	Alliance News	EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	LSE:PIER	Brighton Pier Group Plc (the)
2024/06/01	21 : 01	Alliance News	EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	LSE:LPA	Lpa Group Plc
2024/06/01	21 : 01	Alliance News	EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	LSE:PINE	Pinewood Technologies Group Plc
2024/06/01	21 : 01	Alliance News	EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	LSE:PYC	Physiomics Plc
2024/06/01	21 : 01	Alliance News	EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	LSE:TAVI	Tavistock Investments Plc
2024/06/01	21 : 01	Alliance News	EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	LSE:RTOP	Regtech Open Project Plc
2024/06/01	21 : 01	Alliance News	EXECUTIVE CHANGES: Pendragon chair to remain chair of Pinewood Tech	LSE:RTOP	Regtech Open Project Plc
2024/06/01	21 : 00	NEWSBTC	$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?	COIN:QNTUSD	Quant
2024/06/01	21 : 00	NEWSBTC	$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?	COIN:TRXUSD	TRON
2024/06/01	21 : 00	NEWSBTC	$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?	COIN:FLOWUSD	Flow
2024/06/01	21 : 00	NEWSBTC	$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?	COIN:ETHUSD	Ethereum
2024/06/01	21 : 00	NEWSBTC	$2.5 Billion In Bitcoin Flows Out Of Centralized Exchanges – Time To Buy?	COIN:BTCUSD	Bitcoin
2024/06/01	21 : 00	Business Wire	Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
2024/06/01	21 : 00	GlobeNewswire Inc.	Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024	NASDAQ:MOLN	Molecular Partners AG
2024/06/01	21 : 00	GlobeNewswire Inc.	CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes
2024/06/01	21 : 00	Business Wire	Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)	NYSE:PFE	Pfizer Inc
2024/06/01	21 : 00	Business Wire	KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer	NYSE:BMY	Bristol Myers Squibb Co
2024/06/01	21 : 00	Business Wire	Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers	NYSE:RCUS	Arcus Biosciences Inc
2024/06/01	21 : 00	GlobeNewswire Inc.	Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting	NASDAQ:KYMR	Kymera Therapeutics Inc
2024/06/01	21 : 00	Business Wire	Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma	NYSE:PFE	Pfizer Inc